Bradmer Pharmaceuticals Inc. to Repurchase up to 8.3 Million of its Common Shares Pursuant to a Substantial Issuer Bid
7/17/2009 7:48:31 AM
More...
|
Bradmer Pharmaceuticals Inc. Announces 2009 First Quarter Operational and Financial Results
5/7/2009 11:50:20 AM
More...
|
Bradmer Pharmaceuticals Inc. Announces 2008 Fourth Quarter and Fiscal Year Operational and Financial Results
3/31/2009 11:20:50 PM
More...
|
Bradmer Pharmaceuticals Inc. Implements Cash Conservation Plan; Company Announces Headcount Reduction; Suspends Patient Enrollment and Contract Manufacturing
3/5/2009 9:06:58 AM
More...
|
Bradmer Pharmaceuticals Inc. Provides Clinical Trial Update and Announces Evaluation of Strategic Alternatives
2/17/2009 7:48:16 AM
More...
|
Bradmer Pharmaceuticals Inc. to Participate in Panel Presentation at RBC Capital Markets Healthcare Conference
12/9/2008 8:31:00 AM
More...
|
Bradmer Pharmaceuticals Inc. Issued Patent in Europe for Use of Neuradiab(TM) to Treat Lymphoma
12/1/2008 9:51:09 AM
More...
|
Bradmer Pharmaceuticals Inc. to Present Poster on Progression Free Survival and Overall Survival Data from Neuradiab(TM) Phase II Trials
11/19/2008 11:48:28 AM
More...
|
Bradmer Pharmaceuticals Inc. Announces 2008 Third Quarter Operational and Financial Results
11/10/2008 10:49:53 PM
More...
|
Bradmer Pharmaceuticals Inc. Sponsors Physician Panel to Raise Awareness of Brain Cancer Treatments
11/5/2008 3:53:13 PM
More...
|
|